Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard A Fox

Showing results (21-30 of 158) with videos related to

Pageof 16
Sort By:
European Journal of Immunology|October 12, 2013
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cellsSarah E Church, Shawn M Jensen, Paul A Antony, et al.
Journal for Immunotherapy of Cancer|March 26, 2015
Preamble to the 2015 SITC immunotherapy biomarkers taskforceLisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Nature Reviews. Clinical Oncology|August 15, 2025
Treatment of NSCLC after chemoimmunotherapy - are we making headway?Martin Reck, Nikolaj Frost, Solange Peters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cellsHong-Ming Hu, Hauke Winter, Jun Ma, et al.
Journal of Translational Medicine|April 27, 2012
Lean oncology: a new model for oncologistsVincenzo Montesarchio, Antonio Maria Grimaldi, Bernard A Fox, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2017
Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-PresentationGuangjie Yu, Tarsem Moudgil, Zhihua Cui, et al.
Current Oncology Reports|August 11, 2005
Immunotherapy for melanoma: the good, the bad, and the futureChristian H Poehlein, Dominik Rüttinger, Jun Ma, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the ArtLisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Journal for Immunotherapy of Cancer|May 19, 2016
Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccineDavid B Page, Tyler W Hulett, Traci L Hilton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cellsShawn M Jensen, Sybren L Meijer, Robert A Kurt, et al.
Pageof 16

Showing results (21-30 of 158) with videos related to

Sort By:
Pageof 16
European Journal of Immunology|October 12, 2013
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cellsSarah E Church, Shawn M Jensen, Paul A Antony, et al.
Journal for Immunotherapy of Cancer|March 26, 2015
Preamble to the 2015 SITC immunotherapy biomarkers taskforceLisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Nature Reviews. Clinical Oncology|August 15, 2025
Treatment of NSCLC after chemoimmunotherapy - are we making headway?Martin Reck, Nikolaj Frost, Solange Peters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cellsHong-Ming Hu, Hauke Winter, Jun Ma, et al.
Journal of Translational Medicine|April 27, 2012
Lean oncology: a new model for oncologistsVincenzo Montesarchio, Antonio Maria Grimaldi, Bernard A Fox, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2017
Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-PresentationGuangjie Yu, Tarsem Moudgil, Zhihua Cui, et al.
Current Oncology Reports|August 11, 2005
Immunotherapy for melanoma: the good, the bad, and the futureChristian H Poehlein, Dominik Rüttinger, Jun Ma, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the ArtLisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Journal for Immunotherapy of Cancer|May 19, 2016
Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccineDavid B Page, Tyler W Hulett, Traci L Hilton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cellsShawn M Jensen, Sybren L Meijer, Robert A Kurt, et al.
Pageof 16